219 related articles for article (PubMed ID: 37296904)
1. Novel
Tembrink M; Gerding WM; Wieczorek S; Mika T; Schroers R; Nguyen HP; Vangala DB; Nilius-Eliliwi V
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296904
[TBL] [Abstract][Full Text] [Related]
2. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
Gerding WM; Tembrink M; Nilius-Eliliwi V; Mika T; Dimopoulos F; Ladigan-Badura S; Eckhardt M; Pohl M; Wünnenberg M; Farshi P; Reimer P; Schroers R; Nguyen HP; Vangala DB
Int J Cancer; 2022 Jun; 150(12):1998-2011. PubMed ID: 35064925
[TBL] [Abstract][Full Text] [Related]
3. Optical Genome Mapping for Cytogenetic Diagnostics in AML.
Nilius-Eliliwi V; Gerding WM; Schroers R; Nguyen HP; Vangala DB
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980569
[TBL] [Abstract][Full Text] [Related]
4. Optical Genome Mapping in Routine Cytogenetic Diagnosis of Acute Leukemia.
Soler G; Ouedraogo ZG; Goumy C; Lebecque B; Aspas Requena G; Ravinet A; Kanold J; Véronèse L; Tchirkov A
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046792
[TBL] [Abstract][Full Text] [Related]
5. Optical Genome Mapping in Routine Human Genetic Diagnostics-Its Advantages and Limitations.
Dremsek P; Schwarz T; Weil B; Malashka A; Laccone F; Neesen J
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946907
[TBL] [Abstract][Full Text] [Related]
6. Optical Genome Mapping as a Diagnostic Tool in Pediatric Acute Myeloid Leukemia.
Suttorp J; Lühmann JL; Behrens YL; Göhring G; Steinemann D; Reinhardt D; Neuhoff NV; Schneider M
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565187
[TBL] [Abstract][Full Text] [Related]
7. Broad genomic workup including optical genome mapping uncovers a
Nilius-Eliliwi V; Tembrink M; Gerding WM; Lubieniecki KP; Lubieniecka JM; Kankel S; Liehr T; Mika T; Dimopoulos F; Döhner K; Schroers R; Nguyen HHP; Vangala DB
Front Oncol; 2022; 12():959243. PubMed ID: 36158701
[TBL] [Abstract][Full Text] [Related]
8. Optical genome mapping in acute myeloid leukemia: a multicenter evaluation.
Levy B; Baughn LB; Akkari Y; Chartrand S; LaBarge B; Claxton D; Lennon PA; Cujar C; Kolhe R; Kroeger K; Pitel B; Sahajpal N; Sathanoori M; Vlad G; Zhang L; Fang M; Kanagal-Shamanna R; Broach JR
Blood Adv; 2023 Apr; 7(7):1297-1307. PubMed ID: 36417763
[TBL] [Abstract][Full Text] [Related]
9. Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia.
Valkama A; Vorimo S; Kumpula TA; Räsänen H; Savolainen ER; Pylkäs K; Mantere T
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831635
[TBL] [Abstract][Full Text] [Related]
10. Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal Rearrangements.
Coccaro N; Zagaria A; Anelli L; Tarantini F; Tota G; Conserva MR; Cumbo C; Parciante E; Redavid I; Ingravallo G; Minervini CF; Minervini A; Specchia G; Musto P; Albano F
Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137002
[TBL] [Abstract][Full Text] [Related]
11. NUP98-PHF23 fusion is recurrent in acute myeloid leukemia and shares gene expression signature of leukemic stem cells.
Ho H; Skaist AM; Pallavajjala A; Yonescu R; Batista D; Wheelan SJ; Ning Y
Leuk Res; 2016 Jun; 45():1-7. PubMed ID: 27060678
[TBL] [Abstract][Full Text] [Related]
12. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
13. Multisite Assessment of Optical Genome Mapping for Analysis of Structural Variants in Constitutional Postnatal Cases.
Iqbal MA; Broeckel U; Levy B; Skinner S; Sahajpal NS; Rodriguez V; Stence A; Awayda K; Scharer G; Skinner C; Stevenson R; Bossler A; Nagy PL; Kolhe R
J Mol Diagn; 2023 Mar; 25(3):175-188. PubMed ID: 36828597
[TBL] [Abstract][Full Text] [Related]
14. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Pratcorona M; Abbas S; Kuipers JE; van Galen JF; Beverloo HB; Sonneveld E; Kaspers GJ; Trka J; Baruchel A; Zimmermann M; Creutzig U; Reinhardt D; Pieters R; Valk PJ; Zwaan CM
Blood; 2011 Sep; 118(13):3645-56. PubMed ID: 21813447
[TBL] [Abstract][Full Text] [Related]
15. Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping.
Neveling K; Mantere T; Vermeulen S; Oorsprong M; van Beek R; Kater-Baats E; Pauper M; van der Zande G; Smeets D; Weghuis DO; Stevens-Kroef MJPL; Hoischen A
Am J Hum Genet; 2021 Aug; 108(8):1423-1435. PubMed ID: 34237281
[TBL] [Abstract][Full Text] [Related]
16. NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia.
Raza-Egilmez SZ; Jani-Sait SN; Grossi M; Higgins MJ; Shows TB; Aplan PD
Cancer Res; 1998 Oct; 58(19):4269-73. PubMed ID: 9766650
[TBL] [Abstract][Full Text] [Related]
17. NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy.
Roussy M; Bilodeau M; Jouan L; Tibout P; Laramée L; Lemyre E; Léveillé F; Tihy F; Cardin S; Sauvageau C; Couture F; Louis I; Choblet A; Patey N; Gendron P; Duval M; Teira P; Hébert J; Wilhelm BT; Choi JK; Gruber TA; Bittencourt H; Cellot S
Genes Chromosomes Cancer; 2018 Jun; 57(6):311-319. PubMed ID: 29427526
[TBL] [Abstract][Full Text] [Related]
18. Optical Genome Mapping Reveals and Characterizes Recurrent Aberrations and New Fusion Genes in Adult ALL.
Vieler LM; Nilius-Eliliwi V; Schroers R; Vangala DB; Nguyen HP; Gerding WM
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980958
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA.
Coccaro N; Anelli L; Zagaria A; Tarantini F; Cumbo C; Tota G; Minervini CF; Minervini A; Conserva MR; Redavid I; Parciante E; Macchia MG; Specchia G; Musto P; Albano F
Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296693
[TBL] [Abstract][Full Text] [Related]
20. Cas9-directed long-read sequencing to resolve optical genome mapping findings in leukemia diagnostics.
de Boer EN; Vroom V; Scheper AJ; Johansson LF; Bosscher L; Rietema N; Commandeur-Jan SZ; Knoers NVAM; Sikkema-Raddatz B; van den Berg E; van Diemen CC
Sci Rep; 2024 Apr; 14(1):8508. PubMed ID: 38605095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
